Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

References for PMC Articles for PubMed (Select 18802149)

1.

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Seibel NL, Steinherz PG, Sather HN, Nachman JB, Delaat C, Ettinger LJ, Freyer DR, Mattano LA Jr, Hastings CA, Rubin CM, Bertolone K, Franklin JL, Heerema NA, Mitchell TL, Pyesmany AF, La MK, Edens C, Gaynon PS.

Blood. 2008 Mar 1;111(5):2548-55. Epub 2007 Nov 26.

2.

A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia.

Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui CH, Downing JR, Campana D.

Blood. 2007 Aug 15;110(4):1271-7. Epub 2007 Apr 24.

3.

Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia.

Martin SB, Mosquera-Caro MP, Potter JW, Davidson GS, Andries E, Kang H, Helman P, Veroff RL, Atlas SR, Murphy M, Wang X, Ar K, Xu Y, Chen IM, Schultz FA, Wilson CS, Harvey R, Bedrick E, Shuster J, Carroll AJ, Camitta B, Willman CL.

Leukemia. 2007 Jun;21(6):1341-4. Epub 2007 Apr 5. No abstract available.

PMID:
17410195
4.

Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.

Hayes DN, Monti S, Parmigiani G, Gilks CB, Naoki K, Bhattacharjee A, Socinski MA, Perou C, Meyerson M.

J Clin Oncol. 2006 Nov 1;24(31):5079-90. Review.

PMID:
17075127
5.

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

Schultz KR, Pullen DJ, Sather HN, Shuster JJ, Devidas M, Borowitz MJ, Carroll AJ, Heerema NA, Rubnitz JE, Loh ML, Raetz EA, Winick NJ, Hunger SP, Carroll WL, Gaynon PS, Camitta BM.

Blood. 2007 Feb 1;109(3):926-35. Epub 2006 Sep 26.

6.

Concordance among gene-expression-based predictors for breast cancer.

Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM.

N Engl J Med. 2006 Aug 10;355(6):560-9.

7.

Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks.

Staal FJ, Cario G, Cazzaniga G, Haferlach T, Heuser M, Hofmann WK, Mills K, Schrappe M, Stanulla M, Wingen LU, van Dongen JJ, Schlegelberger B.

Leukemia. 2006 Aug;20(8):1385-92. Epub 2006 Jun 8.

PMID:
16761018
8.

Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols.

Holleman A, den Boer ML, Cheok MH, Kazemier KM, Pei D, Downing JR, Janka-Schaub GE, Göbel U, Graubner UB, Pui CH, Evans WE, Pieters R.

Blood. 2006 Sep 15;108(6):1984-90. Epub 2006 May 18.

9.

Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2.

Flotho C, Coustan-Smith E, Pei D, Iwamoto S, Song G, Cheng C, Pui CH, Downing JR, Campana D.

Blood. 2006 Aug 1;108(3):1050-7. Epub 2006 Apr 20.

10.

Treatment of acute lymphoblastic leukemia.

Pui CH, Evans WE.

N Engl J Med. 2006 Jan 12;354(2):166-78. Review. No abstract available.

PMID:
16407512
11.

Childhood acute lymphoblastic leukaemia and relapse.

Gaynon PS.

Br J Haematol. 2005 Dec;131(5):579-87. Review.

PMID:
16351633
12.

L2L: a simple tool for discovering the hidden significance in microarray expression data.

Newman JC, Weiner AM.

Genome Biol. 2005;6(9):R81. Epub 2005 Aug 31.

13.

Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.

Lugthart S, Cheok MH, den Boer ML, Yang W, Holleman A, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE.

Cancer Cell. 2005 Apr;7(4):375-86.

14.

A Bayesian network classification methodology for gene expression data.

Helman P, Veroff R, Atlas SR, Willman C.

J Comput Biol. 2004;11(4):581-615.

PMID:
15579233
15.

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE.

N Engl J Med. 2004 Aug 5;351(6):533-42.

16.

Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study.

Borowitz MJ, Pullen DJ, Shuster JJ, Viswanatha D, Montgomery K, Willman CL, Camitta B; Children's Oncology Group study.

Leukemia. 2003 Aug;17(8):1566-72.

PMID:
12886244
17.

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR.

Cancer Cell. 2002 Mar;1(2):133-43.

PMID:
12086872
18.

BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).

Kamps WA, Bökkerink JP, Hakvoort-Cammel FG, Veerman AJ, Weening RS, van Wering ER, van Weerden JF, Hermans J, Slater R, van den Berg E, Kroes WG, van der Does-van den Berg A.

Leukemia. 2002 Jun;16(6):1099-111.

19.

Diagnosis of multiple cancer types by shrunken centroids of gene expression.

Tibshirani R, Hastie T, Narasimhan B, Chu G.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72.

20.

Early resistance to therapy during induction in childhood acute lymphoblastic leukemia.

Brisco MJ, Sykes PJ, Dolman G, Hughes E, Neoh SH, Peng L, Snell LE, Toogood IR, Rice MS, Morley AA.

Cancer Res. 2000 Sep 15;60(18):5092-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk